A Pharmacoeconomic Analysis of In-Hospital Costs Resulting from Reintubation in Preterm Infants Treated with Lucinactant, Beractant, or Poractant Alfa

OBJECTIVES: Reintubation and subsequent mechanical ventilation (MV) in preterm infants after surfactant replacement therapy are associated with excess morbidity and mortality and likely increase in-hospital costs. Specific surfactant therapy selection for prevention of respiratory distress syndrome...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Guardia, Carlos G., Moya, Fernando R., Sinha, Sunil, Simmons, Phillip D., Segal, Robert, Greenspan, Jay S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pediatric Pharmacy Advocacy Group 2012
Gaiak:
Clinical Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3526925/
https://ncbi.nlm.nih.gov/pubmed/23258964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-17.3.220
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak